{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:57:23Z","timestamp":1758401843297},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heme oxygenase-1 (HO-1), a stress-inducible protein with a potential anti-inflammatory effect, plays an important role in skin injury and wound healing. However, the function of HO-1 in cutaneous inflammatory diseases, such as psoriasis, remains unknown. The abnormal activation of Stat3, a known transcription factor that induces inflammation and regulates cell differentiation, is directly involved in the pathogenesis and development of psoriasis. Hence, targeting Stat3 is potentially beneficial in the treatment of psoriasis. In this study, HO-1 activation significantly alleviated the disease-related pathogenesis abnormality. To determine the mechanism by which HO-1 exerts immune protection on Th17-related cytokines, IL6\/IL22-induced Stat3 activation was significantly suppressed, accompanied by decreased cell proliferation and reversed abnormal cell proliferation. Importantly, HO-1-induced Stat3 suppression was mediated through the activation of protein tyrosine phosphatase SHP-1. Overall, our study provides direct evidence indicating that HO-1 might be a useful therapeutic target for psoriasis. SHP-1-mediated suppression of Stat3 activation after HO-1 activation is a unique molecular mechanism for the regulation of Stat3 activation.<\/jats:p>","DOI":"10.1038\/srep21132","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T11:54:56Z","timestamp":1455882896000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling"],"prefix":"10.1038","volume":"6","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangsen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"BFsrep21132_CR1","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/492S50a","volume":"492","author":"JM Crow","year":"2012","unstructured":"Crow, J. M. Psoriasis uncovered. Nature 492, S50\u2013S51 (2012).","journal-title":"Nature"},{"key":"BFsrep21132_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths, C. E. & Barker, J. N. Pathogenesis and clinical features of psoriasis. Lancet 370, 263\u2013271 (2007).","journal-title":"Lancet"},{"key":"BFsrep21132_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","volume":"50","author":"S Sano","year":"2008","unstructured":"Sano, S., Chan, K. S. & DiGiovanni, J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50, 1\u201314 (2008).","journal-title":"J Dermatol Sci"},{"key":"BFsrep21132_CR4","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","volume":"178","author":"PJ Murray","year":"2007","unstructured":"Murray, P. J. The JAK-STAT signaling pathway: input and output integration. J Immunol 178, 2623\u20132629 (2007).","journal-title":"J Immunol"},{"key":"BFsrep21132_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","volume":"98","author":"JF Bromberg","year":"1999","unstructured":"Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295\u2013303 (1999).","journal-title":"Cell"},{"key":"BFsrep21132_CR6","first-page":"205","volume":"16","author":"H Liu","year":"2006","unstructured":"Liu, H. et al. Immunohistochemical localization of activated Stat3 and hTERT protein in psoriasis vulgaris. Eur J Dermatol 16, 205\u2013207 (2006).","journal-title":"Eur J Dermatol"},{"key":"BFsrep21132_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jid.2010.255","volume":"131","author":"K Miyoshi","year":"2011","unstructured":"Miyoshi, K. et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 131, 108\u2013117 (2011).","journal-title":"J Invest Dermatol"},{"key":"BFsrep21132_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.8140422","volume":"264","author":"Z Zhong","year":"1994","unstructured":"Zhong, Z., Wen, Z. & Darnell, J. J. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95\u201398 (1994).","journal-title":"Science"},{"key":"BFsrep21132_CR9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1172\/JCI7924","volume":"104","author":"C Bousquet","year":"1999","unstructured":"Bousquet, C., Susini, C. & Melmed, S. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest 104, 1277\u20131285 (1999).","journal-title":"J Clin Invest"},{"key":"BFsrep21132_CR10","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.2174\/1381612033453749","volume":"9","author":"MJ Alcaraz","year":"2003","unstructured":"Alcaraz, M. J., Fernandez, P. & Guillen, M. I. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 9, 2541\u20132551 (2003).","journal-title":"Curr Pharm Des"},{"key":"BFsrep21132_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2613.2006.00505.x","volume":"88","author":"A Wojas-Pelc","year":"2007","unstructured":"Wojas-Pelc, A. & Marcinkiewicz, J. What is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis. Int J Exp Pathol 88, 95\u2013102 (2007).","journal-title":"Int J Exp Pathol"},{"key":"BFsrep21132_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1034\/j.1600-0625.2000.009005359.x","volume":"9","author":"BJ Nickoloff","year":"2000","unstructured":"Nickoloff, B. J. et al. Is psoriasis a T-cell disease? Exp Dermatol 9, 359\u2013375 (2000).","journal-title":"Exp Dermatol"},{"key":"BFsrep21132_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2133.1995.tb02696.x","volume":"133","author":"IM Leigh","year":"1995","unstructured":"Leigh, I. M. et al. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro . Br J Dermatol 133, 501\u2013511 (1995).","journal-title":"Br J Dermatol"},{"key":"BFsrep21132_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","volume":"50","author":"R Gozzelino","year":"2010","unstructured":"Gozzelino, R., Jeney, V. & Soares, M. P. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50, 323\u2013354 (2010).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFsrep21132_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare, A., Di Meglio, P. & Nestle, F. O. The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129, 1339\u20131350 (2009).","journal-title":"J Invest Dermatol"},{"key":"BFsrep21132_CR16","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","volume":"178","author":"PJ Murray","year":"2007","unstructured":"Murray, P. J. The JAK-STAT signaling pathway: input and output integration. J Immunol 178, 2623\u20132629 (2007).","journal-title":"J Immunol"},{"key":"BFsrep21132_CR17","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/sj.onc.1208469","volume":"24","author":"DJ Dauer","year":"2005","unstructured":"Dauer, D. J. et al. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24, 3397\u20133408 (2005).","journal-title":"Oncogene"},{"key":"BFsrep21132_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1469-7580.2009.01066.x","volume":"214","author":"HH Bragulla","year":"2009","unstructured":"Bragulla, H. H. & Homberger, D. G. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J Anat 214, 516\u2013559 (2009).","journal-title":"J Anat"},{"key":"BFsrep21132_CR19","doi-asserted-by":"publisher","first-page":"17694","DOI":"10.1074\/jbc.272.28.17694","volume":"272","author":"PA Ram","year":"1997","unstructured":"Ram, P. A. & Waxman, D. J. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272, 17694\u201317702 (1997).","journal-title":"J Biol Chem"},{"key":"BFsrep21132_CR20","doi-asserted-by":"publisher","first-page":"23376","DOI":"10.1074\/jbc.272.37.23376","volume":"272","author":"M You","year":"1997","unstructured":"You, M. & Zhao, Z. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells. J Biol Chem 272, 23376\u201323381 (1997).","journal-title":"J Biol Chem"},{"key":"BFsrep21132_CR21","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim, C. S., Fung, T. K., Cheung, W. C., Liang, R. & Kwong, Y. L. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway. Blood 103, 4630\u20134635 (2004).","journal-title":"Blood"},{"key":"BFsrep21132_CR22","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1128\/MCB.16.12.6985","volume":"16","author":"H Jiao","year":"1996","unstructured":"Jiao, H. et al. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 16, 6985\u20136992 (1996).","journal-title":"Mol Cell Biol"},{"key":"BFsrep21132_CR23","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182, 5836\u20135845 (2009).","journal-title":"J Immunol"},{"key":"BFsrep21132_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdermsci.2013.03.006","volume":"71","author":"K Schaper","year":"2013","unstructured":"Schaper, K. et al. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J Dermatol Sci 71, 29\u201336 (2013).","journal-title":"J Dermatol Sci"},{"key":"BFsrep21132_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648\u2013651 (2007).","journal-title":"Nature"},{"key":"BFsrep21132_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/1523-1747.ep12613740","volume":"99","author":"CW Trenam","year":"1992","unstructured":"Trenam, C. W., Blake, D. R. & Morris, C. J. Skin inflammation: reactive oxygen species and the role of iron. J Invest Dermatol 99, 675\u2013682 (1992).","journal-title":"J Invest Dermatol"},{"key":"BFsrep21132_CR27","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/carcin\/bgr225","volume":"32","author":"C Zou","year":"2011","unstructured":"Zou, C. et al. Heme oxygenase-1: a molecular brake on hepatocellular carcinoma cell migration. Carcinogenesis 32, 1840\u20131848 (2011).","journal-title":"Carcinogenesis"},{"key":"BFsrep21132_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/bj3530459","volume":"353","author":"C Hanselmann","year":"2001","unstructured":"Hanselmann, C., Mauch, C. & Werner, S. Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis? Biochem J 353, 459\u2013466 (2001).","journal-title":"Biochem J"},{"key":"BFsrep21132_CR29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s000180050394","volume":"55","author":"AL Mui","year":"1999","unstructured":"Mui, A. L. The role of STATs in proliferation, differentiation, and apoptosis. Cell Mol Life Sci 55, 1547\u20131558 (1999).","journal-title":"Cell Mol Life Sci"},{"key":"BFsrep21132_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","volume":"11","author":"S Sano","year":"2005","unstructured":"Sano, S. et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11, 43\u201349 (2005).","journal-title":"Nat Med"},{"key":"BFsrep21132_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jdermsci.2012.06.008","volume":"67","author":"M Fu","year":"2012","unstructured":"Fu, M. & Wang, G. Keratin 17 as a therapeutic target for the treatment of psoriasis. J Dermatol SCI 67, 161\u2013165 (2012).","journal-title":"J Dermatol SCI"},{"key":"BFsrep21132_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/ng.665","volume":"42","author":"D Depianto","year":"2010","unstructured":"Depianto, D., Kerns, M. L., Dlugosz, A. A. & Coulombe, P. A. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet 42, 910\u2013914 (2010).","journal-title":"Nat Genet"},{"key":"BFsrep21132_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","volume":"174","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama, H. et al. Dysfunctional blood and target tissue CD4+ CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174, 164\u2013173 (2005).","journal-title":"J Immunol"},{"key":"BFsrep21132_CR34","first-page":"597","volume":"118","author":"HL Ma","year":"2008","unstructured":"Ma, H. L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118, 597\u2013607 (2008).","journal-title":"J Clin Invest"},{"key":"BFsrep21132_CR35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1189\/jlb.0212101","volume":"92","author":"MM Elloso","year":"2012","unstructured":"Elloso, M. M., Gomez-Angelats, M. & Fourie, A. M. Targeting the Th17 pathway in psoriasis. J Leukoc Biol 92, 1187\u20131197 (2012).","journal-title":"J Leukoc Biol"},{"key":"BFsrep21132_CR36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1189\/jlb.70.3.348","volume":"70","author":"CJ Greenhalgh","year":"2001","unstructured":"Greenhalgh, C. J. & Hilton, D. J. Negative regulation of cytokine signaling. J Leukoc Biol 70, 348\u2013356 (2001).","journal-title":"J Leukoc Biol"},{"key":"BFsrep21132_CR37","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182, 5836\u20135845 (2009).","journal-title":"J Immunol"},{"key":"BFsrep21132_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00403-009-0956-4","volume":"301","author":"LJ Ma","year":"2009","unstructured":"Ma, L. J., You, Y., Bai, B. X. & Li, Y. Z. Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs. Arch Dermatol Res 301, 459\u2013466 (2009).","journal-title":"Arch Dermatol Res"},{"key":"BFsrep21132_CR39","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1182\/blood-2005-02-0494","volume":"106","author":"C Chauveau","year":"2005","unstructured":"Chauveau, C. et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106, 1694\u20131702 (2005).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep21132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep21132","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep21132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:30:59Z","timestamp":1672889459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep21132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,2,24]]}},"alternative-id":["BFsrep21132"],"URL":"https:\/\/doi.org\/10.1038\/srep21132","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]},"assertion":[{"value":"19 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21132"}}